Literature DB >> 2355446

Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin.

Y Henkin1, K C Johnson, J P Segrest.   

Abstract

Niacin (nicotinic acid) is available in several forms, including crystalline preparations and various types of sustained-release preparations. Evidence exists that sustained-release niacin, with respect to both dosage and severity, is more hepatotoxic than crystalline niacin. Three patients who developed hepatitis during treatment with sustained-release niacin were rechallenged with equivalent or higher doses of crystalline niacin, with no evidence of recurring hepatocellular damage. Although the mechanism for niacin-induced hepatitis is unknown, these cases support previous observations that crystalline niacin may be less hepatotoxic than sustained-release preparations in certain patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355446

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  The bioavailability of sustained release nicotinic acid formulations.

Authors:  P J Neuvonen; L Roivas; K Laine; O Sundholm
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

2.  Niacin--the long and the short of it.

Authors:  M J Malloy; P H Frost; J P Kane
Journal:  West J Med       Date:  1991-10

3.  Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.

Authors:  D J Fischer; L L Knight; R E Vestal
Journal:  West J Med       Date:  1991-10

Review 4.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 6.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

7.  Niacin-Induced Anicteric Microvesicular Steatotic Acute Liver Failure.

Authors:  Kenneth Leung; Michael Quezada; Zhengshan Chen; Gary Kanel; Neil Kaplowitz
Journal:  Hepatol Commun       Date:  2018-09-25

Review 8.  Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis.

Authors:  Xiao Liang; Qin He; Qinghua Zhao
Journal:  Biomed Res Int       Date:  2018-03-05       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.